Recombinant human acidic fibroblast growth factor (rhAFGF), independently developed in China.
An integrated platform covering R&D, manufacturing and marketing, with 33 drug approval numbers.
The Fengxian base covers nearly 100 mu and is built strictly to national GMP requirements.
Product display

Tengrui